177 related articles for article (PubMed ID: 2423484)
21. The complexity of DRw6 and DR5 haplotypes in American blacks demonstrated by serology, cellular typing, and restriction fragment length polymorphism analysis.
Lee KW; Hurley CK; Hartzman R; Johnson AH
Hum Immunol; 1990 Nov; 29(3):202-19. PubMed ID: 1980920
[TBL] [Abstract][Full Text] [Related]
22. Definition of a new supertypic HLA class II determinant (LAR) associated with HLA-DR2 and -DR7.
Colombani M; Sansonetti N; Lepage V; Raffoux C; Colombani J
Tissue Antigens; 1989 Jul; 34(1):35-8. PubMed ID: 2479116
[TBL] [Abstract][Full Text] [Related]
23. Identification of three class II antigens, DR7, MB2, and MT3, from a homozygous human cell line.
Shackelford DA; Strominger JL
Hum Immunol; 1984 Mar; 9(3):159-74. PubMed ID: 6199337
[TBL] [Abstract][Full Text] [Related]
24. HLA-DR generic typing by AFLP.
Yunis I; Salazar M; Yunis EJ
Tissue Antigens; 1991 Aug; 38(2):78-88. PubMed ID: 1683030
[TBL] [Abstract][Full Text] [Related]
25. Cells homozygous for two HLA-DR7-associated HLA-D specificities express highly similar DR molecules but different DQ molecules.
Karr RW; Hsu SH; Bias WB
Hum Immunol; 1986 Feb; 15(2):198-210. PubMed ID: 3081469
[TBL] [Abstract][Full Text] [Related]
26. Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting.
Radka SF; Machamer CE; Cresswell P
Hum Immunol; 1984 Jul; 10(3):177-86. PubMed ID: 6611328
[TBL] [Abstract][Full Text] [Related]
27. Polymorphism of HLA-DRw52-associated DRB1 genes as defined by sequence-specific oligonucleotide probe hybridization and sequencing.
Petersdorf EW; Smith AG; Haase AM; Martin PJ; Hansen JA
Tissue Antigens; 1991 Oct; 38(4):169-77. PubMed ID: 1801307
[TBL] [Abstract][Full Text] [Related]
28. HLA-DR3- and HLA-DR7-restricted T-cell hyporesponsiveness to gluten antigen: a clue to the aetiology of coeliac disease?
Scott H; Hirschberg H; Thorsby E
Scand J Immunol; 1983 Aug; 18(2):163-7. PubMed ID: 6603652
[TBL] [Abstract][Full Text] [Related]
29. A monoclonal antibody recognizing HLA-DR2 on malignant and activated cells.
Fuggle SV; Kirkley J; Ting A; Morris PJ
Immunogenetics; 1983; 18(4):415-28. PubMed ID: 6195109
[TBL] [Abstract][Full Text] [Related]
30. A novel HLA-D/DR-like antigen specific for human B lymphoid cells. Biochemical evidence for similarity to but nonidentity with known HLA-D/DR antigens.
Marti GE; Kuo MC; Shaw S; Chang CC; Demars R; Sogn JA; Coligan JE; Kindt TJ
J Exp Med; 1983 Dec; 158(6):1924-37. PubMed ID: 6606012
[TBL] [Abstract][Full Text] [Related]
31. Further characterization of two "DR supertypic" specificities. Additional evidence that they reside on molecules different from those carrying HLA-DR locus specificities.
Tanigaki N; Tosi R; Centis D; Ferrara GB; Pressman D
Hum Immunol; 1981 Oct; 3(2):93-108. PubMed ID: 6173362
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis.
Sorrentino R; Lillie J; Strominger JL
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3794-8. PubMed ID: 2582424
[TBL] [Abstract][Full Text] [Related]
33. A cytotoxic monoclonal antibody (HU-39) that detects DRw8 + DRw12.
Nakayama T; Ogasawara K; Ikeda H; Kunikane H; Kasahara M; Ishikawa N; Fukasawa Y; Hawkin S; Kojima H; Wakisaka A
Hum Immunol; 1987 Jun; 19(2):117-26. PubMed ID: 3497138
[TBL] [Abstract][Full Text] [Related]
34. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
Weyand CM; Hicok KC; Goronzy JJ
J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
[TBL] [Abstract][Full Text] [Related]
35. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
Matsuyama T; Schwenzer J; Silver J; Winchester R
J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
[TBL] [Abstract][Full Text] [Related]
36. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
37. HLA-DR antigens and phenotypes in Dutch coeliac children and their families.
Mearin ML; Bouquet J; Mourad N; Schoorel E; Sinaasappel M; Biemond I; Schreuder GM; Peña AS; van Gelderen HH; van Rood JJ
Clin Genet; 1985 Jan; 27(1):45-50. PubMed ID: 3872185
[TBL] [Abstract][Full Text] [Related]
38. A supertypic HLA-DR specificity (DR4+5) defined by murine monoclonal antibody.
Hansen JA; Martin PJ; Kamoun M; Nisperos B; Thomas ED
Hum Immunol; 1981 Mar; 2(2):103-11. PubMed ID: 6167554
[TBL] [Abstract][Full Text] [Related]
39. A monoclonal antibody that detects a polymorphic determinant common to HLA-DR1 and 2.
Kasahara M; Ogasawara K; Ikeda H; Okuyama T; Ishikawa N; Takenouchi T; Wakisaka A; Kikuchi Y; Aizawa M
Tissue Antigens; 1983 Feb; 21(2):105-13. PubMed ID: 6189259
[TBL] [Abstract][Full Text] [Related]
40. An antiviral T-cell clone defines a functional supertypic specificity shared by different HLA-DR molecules from DR2-short, DRw11, and DRw13 haplotypes.
Zeliszewski D; Sterkers G; Choppin J; Freidel C; Gebuhrer L; Betuel H; Levy JP
Immunogenetics; 1987; 25(2):84-90. PubMed ID: 3493215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
